The world continues to fail to develop the much needed antibacterial drugs despite increasing awareness about the threat of antibiotic resistance, stated a report by the World Health Organization. 

The WHO has noted that none of the 43 antibiotics that are under clinical development at present sufficiently attend to the issue of drug resistance in the world’s most dangerous bacteria. According to Dr. Hanan Balkhy, WHO Assistant Director General on antimicrobial resistance (AMR), the continuous failure to develop, manufacture, and distribute potent new antibiotics is strengthening the impact of AMR and puts our potential to successfully treat bacterial infections in jeopardy. Almost all the new antibiotics that have been introduced into the market over the recent decades are variations of drug classes that had been discovered by 1980s… (WHO, April 15, 2021)